Vanguard Capital Wealth Advisors Acurx Pharmaceuticals, Inc. Put Options Transaction History
Vanguard Capital Wealth Advisors
- $98.5 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ACXP
# of Institutions
31Shares Held
3.68MCall Options Held
100Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ2.04MShares$9.14 Million6.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA529KShares$2.37 Million0.0% of portfolio
-
Prospect Financial Services LLC Melville, NY367KShares$1.64 Million0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA146KShares$654,4250.0% of portfolio
-
Morgan Stanley New York, NY106KShares$474,7180.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $51.7M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...